207 related articles for article (PubMed ID: 26560447)
21. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
Zhao S; Wang J; Qin C
J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
[TBL] [Abstract][Full Text] [Related]
22. OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
Yang W; Wang C; Lin Y; Liu Q; Yu LX; Tang L; Yan HX; Fu J; Chen Y; Zhang HL; Tang L; Zheng LY; He YQ; Li YQ; Wu FQ; Zou SS; Li Z; Wu MC; Feng GS; Wang HY
J Hepatol; 2012 Sep; 57(3):613-20. PubMed ID: 22612999
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
24. Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells.
Friand V; Haddad O; Papy-Garcia D; Hlawaty H; Vassy R; Hamma-Kourbali Y; Perret GY; Courty J; Baleux F; Oudar O; Gattegno L; Sutton A; Charnaux N
Glycobiology; 2009 Dec; 19(12):1511-24. PubMed ID: 19717493
[TBL] [Abstract][Full Text] [Related]
25. Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1.
Tang Y; Lu Y; Chen Y; Luo L; Cai L; Peng B; Huang W; Liao H; Zhao L; Pan M
J Exp Clin Cancer Res; 2019 Nov; 38(1):473. PubMed ID: 31752959
[TBL] [Abstract][Full Text] [Related]
26. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML
Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
[TBL] [Abstract][Full Text] [Related]
27. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling.
Wang J; Wang H; Cai J; Du S; Xin B; Wei W; Zhang T; Shen X
Exp Cell Res; 2018 Apr; 365(1):12-23. PubMed ID: 29453972
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
Fernandis AZ; Cherla RP; Ganju RK
J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
[TBL] [Abstract][Full Text] [Related]
29. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.
Liepelt A; Tacke F
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G203-9. PubMed ID: 27313175
[TBL] [Abstract][Full Text] [Related]
30. Chemokine CXCL12 uses CXCR4 and a signaling core formed by bifunctional Akt, extracellular signal-regulated kinase (ERK)1/2, and mammalian target of rapamycin complex 1 (mTORC1) proteins to control chemotaxis and survival simultaneously in mature dendritic cells.
Delgado-Martín C; Escribano C; Pablos JL; Riol-Blanco L; Rodríguez-Fernández JL
J Biol Chem; 2011 Oct; 286(43):37222-36. PubMed ID: 21878648
[TBL] [Abstract][Full Text] [Related]
31. Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation.
Shibuta K; Mori M; Shimoda K; Inoue H; Mitra P; Barnard GF
Jpn J Cancer Res; 2002 Jul; 93(7):789-97. PubMed ID: 12149145
[TBL] [Abstract][Full Text] [Related]
32. Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo.
Zhu H; Sun Q; Tan C; Xu M; Dai Z; Wang Z; Fan J; Zhou J
Mol Med Rep; 2014 Aug; 10(2):585-92. PubMed ID: 24912495
[TBL] [Abstract][Full Text] [Related]
33. Horizontal transfer of exosomal CXCR4 promotes murine hepatocarcinoma cell migration, invasion and lymphangiogenesis.
Li M; Lu Y; Xu Y; Wang J; Zhang C; Du Y; Wang L; Li L; Wang B; Shen J; Tang J; Song B
Gene; 2018 Nov; 676():101-109. PubMed ID: 30010038
[TBL] [Abstract][Full Text] [Related]
34. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
[TBL] [Abstract][Full Text] [Related]
35. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
36. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
37. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
[TBL] [Abstract][Full Text] [Related]
38. CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.
Kumar R; Tripathi V; Ahmad M; Nath N; Mir RA; Chauhan SS; Luthra K
Cell Immunol; 2012; 272(2):230-41. PubMed ID: 22070874
[TBL] [Abstract][Full Text] [Related]
39. AEG-1 promotes anoikis resistance and orientation chemotaxis in hepatocellular carcinoma cells.
Zhou Z; Deng H; Yan W; Luo M; Tu W; Xia Y; He J; Han P; Fu Y; Tian D
PLoS One; 2014; 9(6):e100372. PubMed ID: 24941119
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
Zhou K; Luo X; Wang Y; Cao D; Sun G
Biomed Pharmacother; 2017 Sep; 93():1025-1032. PubMed ID: 28732393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
